Surgical treatments for lentigo maligna

A review

Michael McLeod, Sonal Choudhary, Georgios Giannakakis, Keyvan Nouri

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

BACKGROUND Since its initial description by Jonathan Hutchinson 120 years ago, a substantial amount of research has occurred to determine the optimum surgical therapy for lentigo maligna (LM). OBJECTIVE To summarize the literature regarding the surgical treatment of LM. METHODS We searched the National Library of Medicine using Pubmed Central and MEDLINE and included as many investigational reports regarding LM therapy that were available in an attempt to form a comprehensive review of surgical modalities. The key words "lentigo maligna,""lentigo maligna treatment,""lentigo maligna therapy," and "lentigo maligna therapeutic modalities" were used. RESULTS We included 12 studies examining staged surgical excision (SSE), nine using Mohs micrographic surgery (MMS), six investigating cryosurgery, 22 investigating imiquimod, seven using lasers, nine investigating radiation therapy, and two investigating electrosurgery and curettage. CONCLUSIONS SSE and MMS are associated with the lowest recurrence rates for LM. Cryotherapy and radiation therapy may be considered the options for treatment of LM in patients who cannot tolerate surgery. Imiquimod, although not currently approved by the FDA, has shown some efficacy in limited experimental studies and may play a future role in the treatment of LM.

Original languageEnglish
Pages (from-to)1210-1228
Number of pages19
JournalDermatologic Surgery
Volume37
Issue number9
DOIs
StatePublished - Sep 1 2011

Fingerprint

Hutchinson's Melanotic Freckle
imiquimod
Mohs Surgery
Therapeutics
Radiotherapy
Electrosurgery
National Library of Medicine (U.S.)
Cryosurgery
Cryotherapy
Curettage
PubMed
MEDLINE
Lasers

ASJC Scopus subject areas

  • Dermatology
  • Surgery

Cite this

Surgical treatments for lentigo maligna : A review. / McLeod, Michael; Choudhary, Sonal; Giannakakis, Georgios; Nouri, Keyvan.

In: Dermatologic Surgery, Vol. 37, No. 9, 01.09.2011, p. 1210-1228.

Research output: Contribution to journalArticle

McLeod, Michael ; Choudhary, Sonal ; Giannakakis, Georgios ; Nouri, Keyvan. / Surgical treatments for lentigo maligna : A review. In: Dermatologic Surgery. 2011 ; Vol. 37, No. 9. pp. 1210-1228.
@article{cd0205e648c64022a2e8cb8379d2ba99,
title = "Surgical treatments for lentigo maligna: A review",
abstract = "BACKGROUND Since its initial description by Jonathan Hutchinson 120 years ago, a substantial amount of research has occurred to determine the optimum surgical therapy for lentigo maligna (LM). OBJECTIVE To summarize the literature regarding the surgical treatment of LM. METHODS We searched the National Library of Medicine using Pubmed Central and MEDLINE and included as many investigational reports regarding LM therapy that were available in an attempt to form a comprehensive review of surgical modalities. The key words {"}lentigo maligna,{"}{"}lentigo maligna treatment,{"}{"}lentigo maligna therapy,{"} and {"}lentigo maligna therapeutic modalities{"} were used. RESULTS We included 12 studies examining staged surgical excision (SSE), nine using Mohs micrographic surgery (MMS), six investigating cryosurgery, 22 investigating imiquimod, seven using lasers, nine investigating radiation therapy, and two investigating electrosurgery and curettage. CONCLUSIONS SSE and MMS are associated with the lowest recurrence rates for LM. Cryotherapy and radiation therapy may be considered the options for treatment of LM in patients who cannot tolerate surgery. Imiquimod, although not currently approved by the FDA, has shown some efficacy in limited experimental studies and may play a future role in the treatment of LM.",
author = "Michael McLeod and Sonal Choudhary and Georgios Giannakakis and Keyvan Nouri",
year = "2011",
month = "9",
day = "1",
doi = "10.1111/j.1524-4725.2011.02042.x",
language = "English",
volume = "37",
pages = "1210--1228",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Surgical treatments for lentigo maligna

T2 - A review

AU - McLeod, Michael

AU - Choudhary, Sonal

AU - Giannakakis, Georgios

AU - Nouri, Keyvan

PY - 2011/9/1

Y1 - 2011/9/1

N2 - BACKGROUND Since its initial description by Jonathan Hutchinson 120 years ago, a substantial amount of research has occurred to determine the optimum surgical therapy for lentigo maligna (LM). OBJECTIVE To summarize the literature regarding the surgical treatment of LM. METHODS We searched the National Library of Medicine using Pubmed Central and MEDLINE and included as many investigational reports regarding LM therapy that were available in an attempt to form a comprehensive review of surgical modalities. The key words "lentigo maligna,""lentigo maligna treatment,""lentigo maligna therapy," and "lentigo maligna therapeutic modalities" were used. RESULTS We included 12 studies examining staged surgical excision (SSE), nine using Mohs micrographic surgery (MMS), six investigating cryosurgery, 22 investigating imiquimod, seven using lasers, nine investigating radiation therapy, and two investigating electrosurgery and curettage. CONCLUSIONS SSE and MMS are associated with the lowest recurrence rates for LM. Cryotherapy and radiation therapy may be considered the options for treatment of LM in patients who cannot tolerate surgery. Imiquimod, although not currently approved by the FDA, has shown some efficacy in limited experimental studies and may play a future role in the treatment of LM.

AB - BACKGROUND Since its initial description by Jonathan Hutchinson 120 years ago, a substantial amount of research has occurred to determine the optimum surgical therapy for lentigo maligna (LM). OBJECTIVE To summarize the literature regarding the surgical treatment of LM. METHODS We searched the National Library of Medicine using Pubmed Central and MEDLINE and included as many investigational reports regarding LM therapy that were available in an attempt to form a comprehensive review of surgical modalities. The key words "lentigo maligna,""lentigo maligna treatment,""lentigo maligna therapy," and "lentigo maligna therapeutic modalities" were used. RESULTS We included 12 studies examining staged surgical excision (SSE), nine using Mohs micrographic surgery (MMS), six investigating cryosurgery, 22 investigating imiquimod, seven using lasers, nine investigating radiation therapy, and two investigating electrosurgery and curettage. CONCLUSIONS SSE and MMS are associated with the lowest recurrence rates for LM. Cryotherapy and radiation therapy may be considered the options for treatment of LM in patients who cannot tolerate surgery. Imiquimod, although not currently approved by the FDA, has shown some efficacy in limited experimental studies and may play a future role in the treatment of LM.

UR - http://www.scopus.com/inward/record.url?scp=80052323294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052323294&partnerID=8YFLogxK

U2 - 10.1111/j.1524-4725.2011.02042.x

DO - 10.1111/j.1524-4725.2011.02042.x

M3 - Article

VL - 37

SP - 1210

EP - 1228

JO - Dermatologic Surgery

JF - Dermatologic Surgery

SN - 1076-0512

IS - 9

ER -